|
| Press Releases |
|
 |
|
| Tuesday, March 3, 2026 |
|
|
華領醫藥宣佈多格列艾汀在中國香港獲批上市 |
| 華領醫藥（「公司」，香港聯交所股份代號：2552）今日宣佈，其全球首創新藥葡萄糖激酶激活劑（GKA）多格列艾汀（dorzagliatin）（商品名：MYHOMSIS(R)，華領片(R)）已獲中國香港特別行政區政府衛生署藥物辦公室批准上市，用於治療成人2型糖尿病。 more info >> |
|
|
华领医药宣布多格列艾汀在中国香港获批上市 |
| 华领医药（"公司"，香港联交所股份代号：2552）今日宣布，其全球首创新药葡萄糖激酶激活剂（GKA）多格列艾汀（dorzagliatin）（商品名：MYHOMSIS(R)，華領片(R)）已获中国香港特别行政区政府卫生署药物办公室批准上市，用于治疗成人2型糖尿病。 more info >> |
|
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China |
| Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GKA) dorzagliatin (Trade name: MYHOMSIS(R)) has been approved for marketing by the Pharmaceutical Service of the Department of Health of the Hong Kong Special Administrative Region of China for the treatment of Type 2 diabetes in adults. more info >> |
|
| Monday, September 29, 2025 |
|
|
Hua Medicine Announces the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin |
| Hua Medicine (HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative Region of China accepted a New Drug Application (NDA) for dorzagliatin, the world's first glucokinase activator (GKA) approved for the treatment of Type 2 diabetes (T2D). more info >> |
|
|
华领医药宣布中国香港卫生署药物办公室正式受理多格列艾汀新药上市许可申请 |
| 华领医药（"公司"，香港联交所股份代号：2552）宣布，中国香港特别行政区卫生署已正式受理多格列艾汀（dorzagliatin）的新药上市许可申请（NDA）。多格列艾汀是世界上第一个获批准用于治疗2型糖尿病（T2D）的葡萄糖激酶激活剂（GKA）。 more info >> |
|
|
華領醫藥宣佈中國香港衛生署藥物辦公室正式受理多格列艾汀新藥上市許可申請 |
| 華領醫藥（"公司"，香港聯交所股份代號：2552）宣佈，中國香港特別行政區衛生署已正式受理多格列艾汀（dorzagliatin）的新藥上市許可申請（NDA）。多格列艾汀是世界上第一個獲批准用于治療2型糖尿病（T2D）的葡萄糖激酶激活劑（GKA）。 more info >> |
|
| Thursday, August 28, 2025 |
|
|
Hua Medicine Announces 2025 Interim Results |
| Hua Medicine (the 'Company', HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2025 (the 'Reporting Period'), as well as the Company's business progress during the first half of the year and future outlook. During the Reporting Period, the commercialization of the Company's core product, HuaTangNing'(dorzagliatin tablets), accelerated. The Company's independent operational capabilities improved significantly. more info >> |
|
|
華領醫藥公佈2025年中期業績 |
| 華領醫藥（"公司"，香港聯交所股份代號：2552）宣佈公司及其附屬公司截至2025年6月30日止六個月（"報告期"）未經審核的綜合業績，以及公司上半年業務進展與未來展望。報告期內，公司核心產品华堂宁(R)（多格列艾汀片）商業化加速，自主運營能力顯著提升，研發進展順利推進，財務表現實現突破性成長，為長期可持續發展奠定了堅實基礎。 more info >> |
|
|
华领医药公布2025年中期业绩 |
| 华领医药（"公司"，香港联交所股份代号：2552）宣布公司及其附属公司截至2025年6月30日止六个月（"报告期"）未经审核的综合业绩，以及公司上半年业务进展与未来展望。 more info >> |
|
| Monday, June 23, 2025 |
|
|
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis |
| Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Maxon、リアルタイム建築ビジュアライゼーションソリューションでAEC市場に正式参入
Mar 17, 2026 23:05: JST
|
|
|
Maxon, 실시간 Archviz 솔루션으로 AEC 시장 공식 진출
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出即時Archviz解決方案，正式進軍AEC市場
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出实时Archviz解决方案，正式进军AEC市场
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon Marks Its Official Entry Into the AEC Market With Its Real-Time Archviz Solution
Mar 17, 2026 22:05 HKT/SGT
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00: JST
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00 HKT/SGT
|
|
|
Geo Energy's Integrated Infrastructure Project Achieves 80% Completion; Secures Two Binding Term Sheets with Third Parties for 9 Million Tonnes Annual Haulage; Coal Prices Surge Amid Global Tensions
Mar 17, 2026 22:00 HKT/SGT
|
|
|
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41: JST
|
|
|
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41 JST
|
|
|
鍋圈(2517.HK)核心經營利潤勁增 四店齊發驅動長期成長
Mar 17, 2026 20:30 HKT/SGT
|
|
|
锅圈(2517.HK)核心经营利润劲增 四店齐发驱动长期成长
Mar 17, 2026 20:24 HKT/SGT
|
|
|
GUOQUAN FOOD (2517.HK) Surging core operating profit, Four Stores Jointly Advancing with Concerted Efforts for Long-Term Growth
Mar 17, 2026 20:15 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL GROUP Provides Medals, Commemorative Items, and Trophies as Category Sponsor (Awards Ceremonies) for the LIGA.i Blind Soccer Top League 2025
Mar 17, 2026 21:00 JST
|
|
|
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
Mar 17, 2026 19:49 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
